Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
OHR-102 Phase 3 Program in Wet-AMD to be Initiated Upon Completion of SPA; Enroll Patients in Q1 2016 Conference Call and Webcast with Slides, Today at 5:00pm Eastern Time NEW YORK, Dec. 10,...
-
AMES, Iowa, Dec. 10, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel...
-
Dublin, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/p7h35d/the_global) has announced the addition of the "The Global Genetic...
-
Dublin, Dec. 09, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/944mqr/europe) has announced the addition of the "Europe Biosimilars Market...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 9, 2015) - bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
-
CUDC-907 (HDAC and PI3K inhibitor) demonstrates objective responses, including complete responses, in patients with relapsed/ refractory DLBCL with MYC alterations Curis expects to initiate a...
-
SOUTH SAN FRANCISCO, Calif., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing novel protein...
-
LEXINGTON, Mass., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
-
WINNERSH, UNITED KINGDOM--(Marketwired - Dec 2, 2015) - Vernalis plc (LSE: VER) (OTC PINK: VNLPY) will hold its Annual General Meeting ("AGM") in London at 10.30am today. The Company issues the...
-
TEL AVIV, Israel, Dec. 1, 2015 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), today announced the grant of US Patent No. 9,200,056, entitled "A Fas-Chimera Adenovirus Vector" by the United State...